Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Original Research Article


Evaluation of Gentamicin-Entrapped Solid Lipid Microparticles Formulated with a Biodegradable Homolipid from Capra hircus

 

FC Kenechukwu1*, CE Umeyor2, MA Momoh1, JDN Ogbonna1, SA Chime3, PO Nnamani1 and AA Attama1

1Department of Pharmaceutics, University of Nigeria, Nsukka 410001, 2Department of Pharmaceutics and Pharmaceutical Technology, Nnamdi Azikiwe University, Awka, 3Department of Pharmaceutical Technology and Industrial Pharmacy, University of Nigeria, Nsukka 410001, Nigeria

 

*For correspondence: Email: chimafrankduff@yahoo.com; frankline.kenechukwu@unn.edu.ng; Tel: +234 8038362638; Fax: +234-42-771709

 

Received: 5 October 2013                                                                     Revised accepted: 15 June 2014

 

Tropical Journal of Pharmaceutical Research, August 2014; 13(8): 1199-1205

http://dx.doi.org/10.4314/tjpr.v13i8.2   

Abstract

 

Purpose: To formulate solidified reverse micellar solutions (SRMS)-based solid lipid microparticles (SLMs) using homolipid from Capra hircus, and evaluate its suitability for the delivery of gentamicin.

Methods: SLMs were formulated by melt-emulsification using SRMS (15 % w/w Phospholipon® 90G in 35 % w/w Capra hircus), PEG 4000 and gentamicin (1.0, 2.0 and 3.0 % w/w), and characterized with respect to size, morphology, encapsulation efficiency (EE) and pH-dependent stability. In vitro release of gentamicin from the SLMs was performed in phosphate buffer (pH 7.4) while bioevaluation was carried out using clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus. 

Results: Stable and discrete SLMs of size range 1.47 ± 0.02 to 3.55 ± 0.09 µm were obtained. The SLMs showed a biphasic pattern of drug release and exhibited time-dependent and capacity-limited bioactivity. Overall, SLMs containing 2 % w/w SRMS, 3 % w/w gentamicin and PEG 4000  entrapped the highest amount of drug, released 99 % of drug and  gave the highest inhibitory zone diameter (IZD) against the organisms within 420 min, while plain gentamicin gave the least.

Conclusion: SRMS-based SLMs prepared with homolipid from Capra hircus offers a suitable delivery system for gentamicin.

 

Keywords: Solid lipid microparticles, Gentamicin, Capra hircus, Phospholipon® 90 G, Solidified reverse micellar solution

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net